Research Articles | Page 23 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Current State of the Art: Management of Higher Risk Myelodysplastic Syndromes Aug 2016 Clin Lymphoma Myeloma Leuk. myelodysplastic syndromes (MDS)
Current therapy of myelodysplastic syndromes. Jul 2013 Blood Rev myelodysplastic syndromes (MDS)
Cutting edge: flow cytometry in myelodysplastic syndromes Jul 2013 J Natl Compr Canc Netw myelodysplastic syndromes (MDS)
Cutting the cord from myelodysplastic syndromes: chronic myelomonocytic leukemia-specific biology and management strategies Mar 2015 Curr Opin Hematol myelodysplastic syndromes (MDS)
Cyclophosphamide in severe aplastic anemia? Oct 2014 Blood aplastic anemia
Cyclosporine Enhances the Sensitivity to Lenalidomide in MDS/AML in Vitro Jun 2020 Experimental Hematology acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
Cyclosporine Enhances the Sensitivity to Lenalidomide in MDS/AML in Vitro May 2020 Experimental Hematology myelodysplastic syndromes (MDS)
Cytogenetic risk stratification in myelodysplastic syndromes: are we there yet? Jul 2012 J Clin Oncol myelodysplastic syndromes (MDS)
Cytogenetics in benzene-associated myelodysplastic syndromes and acute myeloid leukemia: new insights into a disease continuum Mar 2014 Ann N Y Acad Sci myelodysplastic syndromes (MDS)
Danicopan: an oral complement factor D inhibitor for paroxysmal nocturnal hemoglobinuria Oct 2020 Haematologica paroxysmal nocturnal hemoglobinuria (PNH)
Share with addtoany.com.